Erasca to Present at Upcoming Investor Conferences in June

Company Overview - Erasca, Inc. is a clinical-stage precision oncology company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers [2] - The company aims to "erase cancer" by creating novel therapies and combination regimens that comprehensively shut down the RAS/MAPK pathway [2] Upcoming Events - Management will participate in the Jefferies Global Healthcare Conference from June 3-5, 2025, with a fireside chat scheduled for June 4 at 5:30 pm Eastern Time [1] - The company will also attend the Goldman Sachs 46th Annual Global Healthcare Conference from June 9-11, 2025, with a fireside chat on June 10 at 2:40 pm Eastern Time [1] - Live audio webcasts of these events will be available on Erasca's website, with archived replays accessible for 30 days post-event [1]